Aigen Investment Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,190
Closed -$223K 732
2024
Q4
$223K Buy
+3,190
New +$265K 0.04% 576
2024
Q2
Sell
-10,424
Closed -$1.16M 738
2024
Q1
$1.16M Sell
10,424
-12,436
-54% -$1.48M 0.25% 112
2023
Q4
$2.96M Buy
+22,860
New +$3.15M 0.53% 26
2023
Q2
Sell
-9,481
Closed -$1.26M 714
2023
Q1
$1.26M Buy
+9,481
New +$1.11M 0.17% 145
2020
Q4
Sell
-18,620
Closed -$410K 748
2020
Q3
$410K Buy
+18,620
New +$475K 0.05% 442

Other funds holding ACLS

Aigen Investment Management's ACLS Position: Q1 2025 in Review

Aigen Investment Management sold out of Axcelis (ACLS) in Q1 2025, closing a stake of 3,190 shares — an estimated $223K sold.

Aigen Investment Management first reported a position in ACLS in Q3 2020 and held it in 5 quarters. The position peaked at $2.96M in Q4 2023. 306 funds tracked by Wall St. Rank hold ACLS as of Q1 2025.

  • Aigen Investment Management reported no remaining Axcelis position as of Q1 2025 after selling out during the quarter.
  • Aigen Investment Management sold 3,190 Axcelis shares in Q1 2025, an estimated $223K.
  • Aigen Investment Management first reported a position in Axcelis in Q3 2020 and held it in 5 quarters.
  • Aigen Investment Management's Axcelis position peaked at $2.96M in Q4 2023.
  • 306 funds tracked by Wall St. Rank held Axcelis as of Q1 2025.

Based on Aigen Investment Management's 13F filing for Q1 2025, filed 12 May 2025.